(Q35613754)

9 August 2017

1 reference

title

Psychotic bipolar disorders: dimensionally similar to or categorically different from schizophrenia? (English)

1 reference

9 August 2017

0 references

1 reference

1

Terence A Ketter

1 reference

9 August 2017

Po W Wang

2

1 reference

9 August 2017

Olga V Becker

series ordinal

3

1 reference

9 August 2017

Cecylia Nowakowska

series ordinal

4

1 reference

9 August 2017

Yen shou Yang

series ordinal

5

1 reference

9 August 2017

publication date

1 January 2004

1 reference

Journal of Psychiatric Research

9 August 2017

published in

1 reference

9 August 2017

volume

38

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

47-61

1 reference

Importance of schizophrenic symptoms in the diagnosis of mania

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

The genetics of schizophrenia: a reassessment using modern criteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Flupenthixol decanoate in recurrent manic-depressive illness. A comparison with lithium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Switching From 'Unipolar' to Bipolar II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Amygdala enlargement in bipolar disorder and hippocampal reduction in schizophrenia: an MRI study demonstrating neuroanatomic specificity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Genetic antecedents of dopamine dysfunction in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Thought, language, and communication disorders. I. Clinical assessment, definition of terms, and evaluation of their reliability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Thought, language, and communication disorders. II. Diagnostic significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Bipolar manic-depressive psychoses: results of a genetic investigation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

CSF monoamine metabolites in melancholia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Correlation between cerebrospinal fluid amine metabolites and psychomotor activity in affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Schizoaffective illness, schizophrenia and affective disorders: morbidity risk and genetic transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Modern research criteria and the genetics of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Bipolar disorder, schizoaffective disorder and schizophrenia: epidemiologic, clinical and prognostic differences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Psychotic versus nonpsychotic bipolar outpatient depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Is the mechanism of prefrontal hypofunction in depression the same as in schizophrenia? Regional cerebral blood flow during cognitive activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Are schizophrenic and bipolar disorders related? A review of family and molecular studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Molecular linkage studies of bipolar disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Psychotic and neurotic depression: 2. Clinical characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Hallucinations and delusions in 1,715 patients with unipolar and bipolar affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

New concepts in mood stabilization: evidence for the effectiveness of valproate and lamotrigine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

The distinction between the affective psychoses and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Further Evidence of Relation Between Prenatal Famine and Major Affective Disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Heritability estimates for psychotic disorders: the Maudsley twin psychosis series

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

A twin study of genetic relationships between psychotic symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

The stages of mania. A longitudinal analysis of the manic episode.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Are there pathognomonic symptoms in schizophrenia? An empiric investigation of Schneider's first-rank symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Changes in use of valproate and other mood stabilizers for patients with schizophrenia from 1994 to 1998.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Diagnosis and prognosis in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Affective syndromes, psychotic features, and prognosis. II. Mania.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Outcome in schizoaffective, psychotic, and nonpsychotic depression. Course during a six- to 24-month follow-up.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

The Heritability of Schizophrenia and Schizoaffective Disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

The continuum of psychosis and its implication for the structure of the gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

The continuum of psychosis and its genetic origins. The sixty-fifth Maudsley lecture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Differential frontal activation in schizophrenia and bipolar illness during verbal fluency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

The Kraepelinian Dichotomy: Evidence From Developmental and Neuroimaging Studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Dopamine in schizophrenia: a review and reconceptualization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Psychotic and nonpsychotic bipolar mixed states: comparisons with manic and schizoaffective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

A high-density genome scan detects evidence for a bipolar-disorder susceptibility locus on 13q32 and other potential loci on 1q32 and 18p11.2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Suicidality, panic disorder and psychosis in bipolar depression, depressive-mania and pure-mania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Dorsolateral prefrontal cortex dysfunction in the major psychoses; symptom or disease specificity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Complications of pregnancy and delivery in relation to psychosis in adult life: data from the British perinatal mortality survey sample

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Meta-analyses of studies of ventricular enlargement and cortical sulcal prominence in mood disorders. Comparisons with controls or patients with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Twin concordance for DSM-III schizophrenia. Scrutinizing the validity of the definition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Diagnosis and six-month stability of negative symptoms in psychotic disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Mood-congruent versus mood-incongruent psychotic symptoms in first-admission patients with affective disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Six-month stability of psychiatric diagnoses in first-admission patients with psychosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Classification of the depressive disorders by numerical typology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Prevalence of DSM III schizophrenia among the first-degree relatives of schizophrenic probands.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Obstetric complications and schizophrenia: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

CSF neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

A controlled family study of chronic psychoses. Schizophrenia and schizoaffective disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

A Family Study of Schizoaffective, Bipolar I, Bipolar II, Unipolar, and Normal Control Probands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Cerebrospinal fluid amine metabolites in affective illness: the probenecid technique.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Features associated with thought disorder in manic patients at 2-4-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Regional brain function in schizophrenia. II. Repeated evaluation with positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

A follow-up and family study of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Mental disorder and season of birth.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Ten-year outcome: patients with schizoaffective disorders, schizophrenia, affective disorders and mood-incongruent psychotic symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Volumetric MRI measurements in bipolars compared with schizophrenics and healthy controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Bipolar depression: an underestimated treatment challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Prenatal and perinatal risk factors for schizophrenia, affective psychosis, and reactive psychosis of early onset: case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Child development risk factors for adult schizophrenia in the British 1946 birth cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

The long-term natural history of the weekly symptomatic status of bipolar I disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Tardive dyskinesia: prevalence and risk factors, 1959 to 1979.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Epidemiology of puerperal psychoses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Psychiatric illness in first-degree relatives of schizophrenic and surgical control patients. A family study using DSM-III criteria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

The structure of psychosis: latent class analysis of probands from the Roscommon Family Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

The Roscommon Family Study. I. Methods, diagnosis of probands, and risk of schizophrenia in relatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

The Roscommon Family Study. IV. Affective illness, anxiety disorders, and alcoholism in relatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Examining the validity of DSM-III-R schizoaffective disorder and its putative subtypes in the Roscommon Family Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Pre- and perinatal complications and risk for bipolar disorder: a retrospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Endogenous depressions with and without disturbances in the 5-hydroxytryptamine metabolism: A biochemical classification?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

CSF and urinary biogenic amines and metabolites in depression and mania. A controlled, univariate analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

The long-term outcome of Maudsley depressives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Schizophrenia and city life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Obstetric complications, neurodevelopmental deviance, and risk of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Cortical gray matter deficit in patients with bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

The National Depressive and Manic-depressive Association (DMDA) survey of bipolar members

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Genetic independence of manic-depression and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

The effect of serotonergic agents on haloperidol-induced striatal dopamine release in vivo: opposite role of 5-HT(2A) and 5-HT(2C) receptor subtypes and significance of the haloperidol dose used

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Adult major affective disorder after prenatal exposure to an influenza epidemic.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Effect of number of episodes on wellbeing and functioning of patients with bipolar disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Continuity and discontinuity of affective disorders and schizophrenia. Results of a controlled family study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Clinical course and outcome of schizoaffective disorders. A three-year follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Urbanization and psychosis: a study of 1942-1978 birth cohorts in The Netherlands.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

The predictive validity of a diagnosis of schizophrenia. A report from the International Study of Schizophrenia (ISoS) coordinated by the World Health Organization and the Department of Psychiatry, University of Nottingham

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Identical triplets: non-identical psychosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Schizoaffective disorder: is the news of its nonexistence premature? Editor's introduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Relationship between schizoaffective illness and affective disorders or schizophrenia. Morbidity risk and genetic transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Psychometric validation of psychiatric diagnoses in the New York High-Risk Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

The Kraepelinian dichotomy: preliminary results of a 15-year follow-up study on functional psychoses: focus on negative symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Persistent tardive dyskinesia in bipolar patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: a prospective, randomized, double-blind, placebo-controlled, multicenter study. European Valproate Mania Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Higher frequency of neuroleptic-induced dystonia in mania than in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Excess mortality in bipolar and unipolar disorder in Sweden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Mortality and causes of death in schizophrenia in Stockholm county, Sweden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Homovanillic and 5-Hydroxyindoleacetic Acid in Cerebrospinal Fluid of Depressed Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Ziskind-Somerfeld Research Award 1996. Medial and superior temporal gyral volumes and cerebral asymmetry in schizophrenia versus bipolar disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

In Vivo D2 Dopamine Receptor Density in Psychotic and Nonpsychotic Patients With Bipolar Disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

M100,907, a selective 5-HT(2A) antagonist, attenuates dopamine release in the rat medial prefrontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Lithium prophylaxis of bipolar illness. The value of combination treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Cerebrospinal fluid and plasma monoamine metabolites and their relation to psychosis. Implications for regional brain dysfunction in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

"Schizoaffective disorder": an invalid diagnosis? A comparison of schizoaffective disorder, schizophrenia, and affective disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Diagnosis in schizophrenia and manic-depressive illness: a reassessment of the specificity of 'schizophrenic' symptoms in the light of current research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Transduction of psychosocial stress into the neurobiology of recurrent affective disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Predictability as an index of impaired verbal communication in schizophrenic and affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Age at onset and number of psychotic symptoms in bipolar I and schizoaffective disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Toward the validation of RDC schizoaffective disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Cerebrospinal fluid monoamine and monoamine metabolite concentrations in melancholia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

The group of schizophrenias, schizoaffective psychoses, and affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Chronic neuroleptic exposure in bipolar outpatients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Neuroleptic exposure following inpatient treatment of acute mania with lithium and neuroleptic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

A genetic study of affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Adjunctive antipsychotic use in bipolar patients: an open 6-month prospective study following an acute episode

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Twelve-month outcome of patients with DSM-III-R schizoaffective disorder: comparisons to matched patients with bipolar disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

A bidimensional model for diagnosis and classification of functional psychoses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Role of biogenic amines in certain pathological conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Structure of mania: depressive, irritable, and psychotic clusters with different retrospectively-assessed course patterns of illness in randomized clinical trial participants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Are schizophrenia and affective disorder related? A selective literature review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Olanzapine versus divalproex in the treatment of acute mania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

The McLean–Harvard first-episode project: 6-month symptomatic and functional outcome in affective and nonaffective psychosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Prediction of outcome in mania by mood-congruent or mood-incongruent psychotic features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Outcome in Mania. A 4-year prospective follow-up of 75 patients utilizing survival analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Four-year follow-up of twenty-four first-episode manic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Monoamine metabolites in CSF and suicidal behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Long-term outcome of major psychoses. II. Schizoaffective disorder compared with schizophrenia, affective disorders, and a surgical control group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Schizoaffective disorder: concept and reality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Morbidity risks of schizophrenia and affective disorders among first degree relatives of patients with schizophrenia, mania, depression and surgical conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Long-term outcome of major psychoses. I. Schizophrenia and affective disorders compared with psychiatrically symptom-free surgical conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Increased morbid risk for schizophrenia in families of in-patients with bipolar illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Developmental precursors of affective illness in a general population birth cohort.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Risk factors for onset and persistence of psychosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Cerebral monoamines and depression. An investigation with the Probenecid technique.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

A survey of prescribing practice of antipsychotic maintenance treatment for manic-depressive outpatients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Biogenic amine metabolites in cerebrospinal fluid of patients with affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

MRI findings in patients with affective disorder: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

First admission with puerperal psychosis: 7?14 years of follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Cognitive impairment, clinical course and treatment history in out-patients with bipolar affective disorder: relationship to tardive dyskinesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Is there a common denominator for the antimanic effect of lithium and anticonvulsants?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Biology and recent brain imaging studies in affective psychoses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Psychiatric disorders in the relatives of probands with affective disorders. The Yale University--National Institute of Mental Health Collaborative Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Bipolar manic-depressive disorder: A reassessment of course and outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Monoamine metabolites, corticotropin releasing factor and somatostatin as CSF markers in depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Do schizophrenia and affective disorder share susceptibility genes?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Cerebrospinal Fluid Levels of MHPG in Affective Disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Functional magnetic resonance imaging of schizophrenic patients and comparison subjects during word production.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Antipsychotic drug treatment in first-episode mania: a 6-month longitudinal study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

Tardive dyskinesia in bipolar affective disorder: a catchment area study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

inferred from DOI database lookup

7 January 2021

based on heuristic

A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900099-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3956(03)00099-2

1 reference

9 August 2017

1 reference